Sunshine Biopharma Receives Third Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
MONTREAL, QC / ACCESSWIRE / December 1, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
News
CO2 GRO Inc. Announces 30% Accelerated Flowering Results Using CO2 Delivery Solutions(TM) On C4 Orchids
TORONTO, ON / ACCESSWIRE / December 1, 2020 / Toronto based CO2 GRO Inc. ("GROW") (TSXV:GROW, OTCQB:BLONF, Frankfurt:4021) is pleased...
TruckSuite(TM) Now Offering No-Stress Warranty Financing
TORONTO, ON / ACCESSWIRE / December 1, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital"...
Avinger Receives Nasdaq Extension, Recommends Stockholders Vote FOR All Proxy Proposals
REDWOOD CITY, CA / ACCESSWIRE / December 1, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Halberd Corporation Advisory Board Reorganization Announced
JACKSON CENTER, PA / ACCESSWIRE / December 1, 2020 / Halberd Corp. (OTC PINK:HALB) announces the reorganization of its Scientific...
Ovation Science Reports $180,994 in Q3 2020 Revenue; a 129% Increase over Q3 2019
Increase in Revenue Primarily Derived from DermSafe Hand Sanitizer Lotion VANCOUVER, BC / ACCESSWIRE / December 1, 2020 / (CSE:OVAT)(OTC...
Philips highlights its expanding enterprise imaging informatics portfolio at RSNA 2020
Physicians view radiology images on screen Philips Patient Management Solution on a smartphone over two screens. Philips’ Radiology Operations Command...
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001)Results suggest potential for AM-301 nasal spray to...
NanoVapor Biotech Launches OMNISOL® Product Line – New Environmentally-Friendly Products that Make Surfaces Self-Disinfecting to Help Keep Businesses Virus-Free
OMNISOL® goes beyond simply disinfecting to provide long-lasting protection from dangerous pathogens during the pandemic, flu season and beyondHOUSTON, Dec....
Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft
CRANBURY, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing...
Doxy.me Experiences 10X Growth in Provider Users and Reaches Over 100 Million Patient Telehealth Visits
The telemedicine platform surpasses 10,000 clinic sign upsSALT LAKE CITY, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Doxy.me, a free, accessible...
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a planned response to a Complete...
Better Choice Showing Opportunity for Substantial Monetary Savings from Consolidation of Fulfillment Operations
Achieving lower costs, while increasing capacityNEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”),...
CRISPR Therapeutics and Vertex to Host Investor Webcast to Review Data Presented at the 62nd American Society of Hematology Annual (ASH) Meeting and Exposition for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ in Sickle Cell Disease and Beta Thalassemia
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and Vertex Pharmaceuticals...
Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting
- Meeting Highlights Include New Long-Term Data in Tuberous Sclerosis Complex - CARLSBAD, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) --...
Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
WARREN, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Nevada Donor Network and MediGO Launch the First MedTech Partnership That Brings Disruptive Technology to Organ Transplantation
BALTIMORE, Dec. 01, 2020 (GLOBE NEWSWIRE) -- MediGO, the Baltimore-based technology company applying disruptive technology solutions to organ transplantation logistics,...
Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
MONMOUTH JUNCTION, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the...
Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Roluperidone
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the...